MNPR-101-Zr
Phase 1- Indications
- Advanced cancer
Company intelligence / Profile preview
Melbourne Theranostic Innovation Centre
Melbourne, Victoria, Australiamtic.net.au ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
MTIC provides state-of-the-art PET/CT-based precision molecular imaging services for diagnosis and management of cancer patients. It also serves as a site for early-phase clinical trials of novel radiopharmaceuticals. For example, it was the first site to dose a patient in the Phase 1 ZOLAR trial of TLX300-CDx ([^89Zr]-olaratumab) in advanced soft tissue sarcoma[6]. The centre’s integration with academic partners enables rapid translation from preclinical development to human studies.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalRadiopharmaceutical diagnostic agentRadiopharmaceutical therapeutic agent
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
PreMIT Pty Ltd / Precision Molecular Imaging & Theranostics Pty Ltd—R&D affiliate/sister companyUniversity of Melbourne—academic collaboration/radiochemistry lab accessMonash University—academic collaboration/preclinical imaging facilities accessCyclotek Australia Pty Ltd—GMP cyclotron facility/radiotracer manufacturing partnerGenesis Care—a major provider of oncology care in AustraliaTelix Pharmaceuticals Limited—for first-in-human trials such as TLX300-CDx/ZOLAR study at MTIC site.Avion Medical Skin Centres / OncoBeta GmbH—for non-melanoma skin cancer therapy within MTIC facility.
Beyond the preview
Go deeper on Melbourne Theranostic Innovation Centre.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Melbourne Theranostic Innovation Centre.